Evidence map›Paper›PMID 23768516›Full record

ArticleAmerican journal of human genetics2013

Fine mapping of the 1p36 deletion syndrome identifies mutation of PRDM16 as a cause of cardiomyopathy.

Anne-Karin Arndt, Sebastian Schafer, Jorg-Detlef Drenckhahn, M Khaled Sabeh, Eva R Plovie, Almuth Caliebe, Eva Klopocki, Gabriel Musso, Andreas A Werdich, Hermann Kalwa and 15 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 100 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed, 3 pooled it
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 3 syntheses or guidelines pooled it, 208 citations in OpenAlex.

  1. Circulation. Genomic and precision medicine · 2023
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. A novel truncating variant inGenes & diseases · 2026
    Article
  7. Coronary artery disease risk gene PRDM16 regulates smooth muscle homeostasis.Journal of molecular and cellular cardiology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Dilated cardiomyopathy in patients with PRDM16 haploinsufficiency.Journal of molecular medicine (Berlin, Germany) · 2025
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 14 institutions in 5 countries.

Anne-Karin ArndtDepartment of Congenital Heart Disease and Pediatric Cardiology, University Hospital of Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany.
Sebastian Schafer
Jorg-Detlef Drenckhahn
M Khaled Sabeh
Eva R Plovie
Almuth Caliebe
Eva Klopocki
Gabriel Musso
Andreas A Werdich
Hermann Kalwa
Matthias Heinig
Robert F Padera
Katharina Wassilew
Julia Bluhm
Christine Harnack
Janine Martitz
Paul J Barton
Matthias Greutmann
Felix Berger
Norbert Hubner
Reiner Siebert
Hans-Heiner Kramer
Stuart A Cook
Calum A MacRae
Sabine Klaassen
Max Delbrück Center · DEBrigham and Women's Hospital · USHarvard Stem Cell Institute · USUniversity Hospital Schleswig-Holstein · DEBerlin Heart (Germany) · DECharité - Universitätsmedizin Berlin · DEChristian-Albrechts-Universität zu Kiel · DEDeutsches Herzzentrum München · DEDuke-NUS Medical School · SGGerman Centre for Cardiovascular Research · DEImperial College London · GBUniversity Hospital of Zurich · CHUniversity of Lübeck · DEUniversity of Würzburg · DE

Funding

Development of a High-throughput Integrated In Vivo Heart Failure AssayR01HL109264 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MACRAE, CALUM A. · 2012 to 2014
$1.3M
Molecular Mechanisms of Stretch-Induced Electrical Remodeling in the HeartK99HL112724 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI WERDICH, ANDREAS AUGUSTINUS · 2012 to 2013
$265k
British Heart Foundation SP/10/10/28431Medical Research Council MC_U120085815NHLBI NIH HHS K99 HL112724NHLBI NIH HHS R01 HL109264Wellcome Trust
6 · The paper itself

Abstract

Deletion 1p36 syndrome is recognized as the most common terminal deletion syndrome. Here, we describe the loss of a gene within the deletion that is responsible for the cardiomyopathy associated with monosomy 1p36, and we confirm its role in nonsyndromic left ventricular noncompaction cardiomyopathy (LVNC) and dilated cardiomyopathy (DCM). With our own data and publically available data from array comparative genomic hybridization (aCGH), we identified a minimal deletion for the cardiomyopathy associated with 1p36del syndrome that included only the terminal 14 exons of the transcription factor PRDM16 (PR domain containing 16), a gene that had previously been shown to direct brown fat determination and differentiation. Resequencing of PRDM16 in a cohort of 75 nonsyndromic individuals with LVNC detected three mutations, including one truncation mutant, one frameshift null mutation, and a single missense mutant. In addition, in a series of cardiac biopsies from 131 individuals with DCM, we found 5 individuals with 4 previously unreported nonsynonymous variants in the coding region of PRDM16. None of the PRDM16 mutations identified were observed in more than 6,400 controls. PRDM16 has not previously been associated with cardiac disease but is localized in the nuclei of cardiomyocytes throughout murine and human development and in the adult heart. Modeling of PRDM16 haploinsufficiency and a human truncation mutant in zebrafish resulted in both contractile dysfunction and partial uncoupling of cardiomyocytes and also revealed evidence of impaired cardiomyocyte proliferative capacity. In conclusion, mutation of PRDM16 causes the cardiomyopathy in 1p36 deletion syndrome as well as a proportion of nonsyndromic LVNC and DCM.

Indexed as

AnimalsCardiomyopathy, DilatedCase-Control StudiesCell ProliferationChromosome DeletionChromosome DisordersChromosome MappingChromosomes, Human, Pair 1Comparative Genomic HybridizationDNA-Binding ProteinsExonsFrameshift MutationHumansIsolated Noncompaction of the Ventricular MyocardiumMutation, MissenseMyocardial ContractionDNA-Binding ProteinsPRDM16 protein, humanTranscription Factors

Identifiers

PMID23768516
PMCPMC3710750
OpenAlexW2030639394

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.